Drug Shortage Report for ABRILADA

Last updated on 2022-11-29 History
Report ID 173490
Drug Identification Number 02511053
Brand name ABRILADA
Common or Proper name ABRILADA
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ADALIMUMAB
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 40MG / 0.8ML
ATC code L04AB
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-11-28
Actual start date
Estimated end date 2023-01-20
Actual end date
Shortage status Actual shortage
Updated date 2022-11-29
Company comments Abrilada 40mg/0.8mL SSOL 1x2 Pre Filled Syringe currently on Preventive Allocation Abrilada 40mg/0.8mL SSOL 1x2 Pre Filled Pen presentation is available
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-11-29 English Compare
v2 2022-11-03 French Compare
v1 2022-11-03 English Compare

Showing 1 to 3 of 3